| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.25B | -2.8% |
| Cost of Revenue | $2.76B | -2.5% |
| Gross Profit | $1.49B | -3.1% |
| R&D Expense | $95.4M | -15.0% |
| SG&A Expense | $435.9M | -6.9% |
| Operating Income | -$1.12B | -1094.0% |
| Pre-tax Income | -$1.30B | -1508.3% |
| Income Tax | $104.4M | +30.5% |
| Net Income | -$1.43B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $612.8M | -4.6% |
| Inventory | $1.15B | +6.2% |
| Current Assets | $2.80B | +12.7% |
| Total Assets | $8.54B | -11.5% |
| Current Liabilities | $1.01B | -3.0% |
| Long-term Debt | $3.60B | +0.6% |
| Total Liabilities | $5.60B | +5.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $238.5M | -34.3% |
| Capital Expenditures | $93.4M | -21.0% |
| Investing Cash Flow | -$75.4M | -195.7% |
| Financing Cash Flow | -$220.5M | +63.9% |
| Free Cash Flow | $145.1M | -40.7% |
| -729.7% |
| EPS (Basic) | -$10.29 | -723.2% |
| EPS (Diluted) | -$10.29 | -723.2% |
| Stockholders' Equity |
| $2.94B |
| -32.0% |